Panaraian panyakit koronavirus 2019
<!--{{2019–20 coronavirus pandemic sidebar|expanded=medical}}
-->
[[Berkas:CDC 2019-nCoV Laboratory Test Kit.jpg|alt=CDC 2019-nCoV Laboratory Test Kit.jpg|jmpl|upright=1.3|Kit tes penyakit koronavirus 2019 dari CDC]]
{{COVID-19 pandemic sidebar|expanded=medis}}
'''Panaraian panyakit koronavirus 2019''' kawa maminandui virus [[SARS-CoV-2]] wan tamasuk cara-cara nang kawa manggagai kabaradaan virus ngitu, wan jua [[antibodi]] nang dikulih gasan mananggapi pajangkitan virus. Panggagaian antibodi ([[serologi]]) kawa dipakai gasan diagnusis wan panjanakan garumbung. Tarai antibodi manunjukakan barapa banyak urang nang sudah tajangkit panyakit, tamasuk nang baisi simtom minor atawa jua kada baisi simtom (asimtomatis). Saupama damintu, waktu wan kamanjuran (efektivitas) tanggapan imunisasi COVID-19 masih balum jalas.<ref name=JAMA_anibody>{{cite journal |url=https://jamanetwork.com/journals/jama/fullarticle/2764954 |title= The Promise and Peril of Antibody Testing for COVID-19 |publisher=JAMA Network |access-date=20 April 2020|date = 17 April 2020|doi= 10.1001/jama.2020.6170 |last1= Abbasi |first1= Jennifer |journal= JAMA |pmid= 32301958 |doi-access= free }}</ref>

Marga jumlah tarai nang tawatas, maka par Marit 2020 balum ada nagara nang baisi data nang kawa diparcaya gasan jumlah urang nang takana panyakit ngini.<ref>{{cite news|title=A fiasco in the making? As the coronavirus pandemic takes hold, we are making decisions without reliable data|date=17 March 2020|author=Ioannidis, John P.A.|url=https://www.statnews.com/2020/03/17/a-fiasco-in-the-making-as-the-coronavirus-pandemic-takes-hold-we-are-making-decisions-without-reliable-data/|publisher=STAT|accessdate=22 March 2020}}</ref>
Par {{Testing for Coronavirus disease 2019|shortdate}}, nagara-nagara baisi data panaraian wastu gasan {{Testing for Coronavirus disease 2019|avgtested}}% matan jumlah garumbung bubuhannya, wan kadada nagara nang baisi jumlah cuntuh (sampel) labih matan {{Testing for Coronavirus disease 2019|maxtested}}% jumlah garumbungnya.<ref>{{Cite web|url=https://ourworldindata.org/grapher/full-list-cumulative-total-tests-per-thousand|title=Total tests for COVID-19 per 1,000 people|website=Our World in Data|access-date=16 April 2020}}</ref> Tadapat bamamacam jumlah panaraian nng digawi matan nagara ka nagara.<ref>{{cite web |url=https://www.usatoday.com/story/news/world/2020/04/10/coronavirus-covid-19-small-nations-iceland-big-data/2959797001/ |title= Iceland has tested more of its population for coronavirus than anywhere else. Here's what it learned |publisher= USA Today|access-date=16 April 2020|date = 11 April 2020}}</ref> Hal ngini maujaki kaduan jumlah kmatian marga panyakit ngini, nang mungkin labih matan nang dikikiraakan, marga bias pacacahan.<ref name=":1">Ward, D. (April 2020) [https://www.researchgate.net/publication/340539075_Sampling_Bias_Explaining_Wide_Variations_in_COVID-19_Case_Fatality_Rates "Sampling Bias: Explaining Wide Variations in COVID-19 Case Fatality Rates"]. WardEnvironment.</ref><ref>{{Cite web|url=https://www.bbc.com/future/article/20200401-coronavirus-why-death-and-mortality-rates-differ|title=Coronavirus: Why death and mortality rates differ|last=Henriques|first=Martha|website=bbc.com|language=en|access-date=8 April 2020}}</ref><ref>{{cite web |url=https://www.medrxiv.org/content/10.1101/2020.04.02.20050633v2.full.pdf |doi=10.1101/2020.04.02.20050633 |title= Explaining national differences in the mortality of Covid-19: Individual patient simulation model to investigate the effects of testing policy and other factors on apparent mortality |year= 2020 |last1= Michaels |first1= Jonathan A. |last2= Stevenson |first2= Matt D.}}</ref>

== Jujuhutan ==
Panaraian panyakit koronavirus 2019 kawa maminandui virus SARS-CoV-2 wan tamasuk cara-cara nang kawa manggagai kabaradaan virus ngitu, wan jua antibodi nang dikulih gasan mananggapi pajangkitan virus. Panggagaian antibodi (serologi) kawa dipakai gasan diagnusis wan panjanakan garumbung. Tarai antibodi manunjukakan barapa banyak urang nang sudah tajangkit panyakit, tamasuk nang baisi simtom minor atawa jua kada baisi simtom (asimtomatis). Saupama damintu, waktu wan kamanjuran (efektivitas) tanggapan imunisasi COVID-19 masih balum jalas.

Marga jumlah tarai nang tawatas, maka par Marit 2020 balum ada nagara nang baisi data nang kawa diparcaya gasan jumlah urang nang takana panyakit ngini.
Par , nagara-nagara baisi data panaraian wastu gasan % matan jumlah garumbung bubuhannya, wan kadada nagara nang baisi jumlah cuntuh (sampel) labih matan % jumlah garumbungnya. Tadapat bamamacam jumlah panaraian nng digawi matan nagara ka nagara. Hal ngini maujaki kaduan jumlah kmatian marga panyakit ngini, nang mungkin labih matan nang dikikiraakan, marga bias pacacahan.Ward, D. (April 2020) "Sampling Bias: Explaining Wide Variations in COVID-19 Case Fatality Rates". WardEnvironment.

 Jujuhutan